Article
Presence of 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1",2"-oxath iole-2",2"-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients.
AIDS research and human retroviruses - 10 Jun 2000
Van Laethem K, Schmit J C, Pelemans H, Balzarini J, Witvrouw M, Pérez-Pérez M J, Camarasa M J, Esnouf R M, Aquaro S, Cenci A, Perno C F, Hermans P, Sprecher S, Ruiz L, Clotet B, Van Wijngaerden E, Van Ranst M, Desmyter J, De Clercq E, Vandamme A M
Abstract excerpt
HIV-1 samples from six patients undergoing diverse anti-HIV therapies possessed the E138A mutation in their reverse transcriptase (RT) genome. Patients were receiving the following therapies: TIBO monotherapy (one patient); zidovudine plus didanosine combination therapy (one); zidovudine monotherapy (one); sequential therapy with zidovudine, then stavudine and finally zalcitabine plus didanosine (one); and two...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.